Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| AISLING CAPITAL MANAGEMENT LP | 02-07-2024 | 12-31-2023 | 16 | 335,237,494 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc. (BBIO) | COM | 1 | $244,970,206 | 6,068,125 | 0.07 | 0.07 | 0 | 0.00 | 12-31-2023 |
| Verona Pharma plc (VRNA) | SPONSORED ADS | 2 | $22,173,198 | 1,115,352 | 0.01 | 0.01 | 0 | 0.00 | 12-31-2023 |
| Syndax Pharmaceuticals, Inc. (SNDX) | COM | 3 | $22,150,250 | 1,025,000 | 0.01 | 0.01 | 0 | 0.00 | 12-31-2023 |
| Biomea Fusion Inc (BMEA) | COM | 4 | $11,597,952 | 798,757 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
